Spectral Medical Inc T.EDT

Alternate Symbol(s): EDTXF

Spectral Medical Inc. is a Canada-based late-stage theragnostic company advancing therapeutic options for sepsis and septic shock. The Company develops and commercializes a treatment for septic shock utilizing its Endotoxin Activity Assay (EAA) diagnostic and the Toraymyxin therapeutic (PMX). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s EAA. PMX is approved for therapeutic use in Japan and Europe and has been used safely and effectively on more than 340,000 patients to date. It has pioneered the development of biochemical markers for the clinical syndrome known as septic shock. It is continuing its legacy business of manufacturing and selling certain proprietary reagents. It develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies.

TSX:EDT - Post by User

Spectral Medical Inc > Enough option talk kids - I already guessed it yday ; - )

<< Previous

Bullboard Posts

Next >>

Comment by mercedesmanon Mar 03, 2021 10:15am

139 Views

Post# 32704031

RE:Enough option talk kids - I already guessed it yday ; - )

Yes. It's coming up to a year, so as a shareholder, I'm very much looking forward to an update or news on how Spectral has been able to contribute in the fight against Covid (both with PMX/EAA and the Dialco equipment)...

...and to see if they are confirming what other Studies/countries seem to be finding.

MM

<< Previous

Bullboard Posts

Next >>

dynaCERT leans into global growth with new HydraGEN orders